Answers are grounded in this paper and cite their sources.
Investigates folic acid's impact on one-carbon metabolism in maternal and cord blood, indicating its importance for fetal development.
Background/Objectives: Folic acid (FA) intake impacts one-carbon metabolism (OCM), which is crucial for fetal development and epigenetic regulation. While FA supplementation is known to lower homocysteine levels, its comprehensive effects on OCM-related metabolites in maternal and cord blood remain unclear. This study aimed to investigate the association between FA use and serum OCM-related metabolite profiles in Japanese pregnant women. Methods: We analyzed 146 mother-infant pairs from the Chiba study of Mother and Child Health (C-MACH) cohort. Blood samples were collected in early pregnancy, late pregnancy, and at delivery (maternal and cord blood). FA use was assessed via self-administered questionnaires. Serum concentrations of 18 OCM-related metabolites, including 5-methyltetrahydrofolate (5-MTHF) and homocysteine, were measured using LC-MS/MS. Results: FA users exhibited significantly higher 5-MTHF and lower total homocysteine concentrations in maternal blood at all time points and in cord blood compared to non-users. Compared to non-users, FA users exhibited a lower serine/glycine ratio in early pregnancy, a higher betaine/DMG ratio in maternal blood at delivery, and higher S-adenosylmethionine and total cysteine concentrations in maternal blood during late pregnancy. In cord blood, unmetabolized folic acid concentrations did not differ significantly between FA users and non-users. Furthermore, the cord-to-maternal 5-MTHF ratio was significantly lower in FA users. Conclusions: Our findings suggest that FA use during pregnancy may contribute to the optimization of OCM in both the mother and fetus.
No takes yet. Share an insight, caveat, or question.
Kubo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: